Showing 8191-8200 of 20875 results for "".
Incretin-Based Advances in Obesity and T2D Care
https://reachmd.com/programs/diabetes-discourse/incretin-advances-obesity/57025/For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about these care strategies, tune in as Dr. Javier Morales shares key updates from the 2026 American Diabetes AsEncaleret in Autosomal Dominant Hypocalcemia Type 1: Clinical Implications From the Phase 3 CALIBRATE Trial
https://reachmd.com/clinical-practice/endocrinology/encaleret-in-autosomal-dominant-hypocalcemia-type-1-clinical-implications-from-the-phase-3-calibrate-trial/54832/Discover why the phase 3 CALIBRATE trial is generating attention in ADH1 and what emerging data could mean for future disease management.Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease
https://reachmd.com/programs/diabetes-discourse/understanding-dapagliflozin-examining-its-use-in-chronic-kidney-disease/12251/Can a treatment option used for type 2 diabetes help those with chronic kidney disease?Is a Low-Carb, High-Fat Diet the Key to Diabetic Management?
https://reachmd.com/programs/clinicians-roundtable/is-a-low-carb-high-fat-diet-the-key-to-diabetic-management/10040/Dr. Sarah Hallberg discusses how a simple change in diet can lead to improved blood sugar levels and better management of diabetes.ATTRv vs ATTRwt: Hereditary and Wild-Type ATTR-CM
https://reachmd.com/programs/spotlight-attr-cm/hereditary-attrv-vs-wild-type-attrwt-attr-cm/68947/Coping Strategies for Patients Growing up With Chronic Illness
https://reachmd.com/programs/clinicians-roundtable/coping-strategies-for-patients-growing-up-with-chronic-illness/3412/Better technology and treatments mean that people with serious childhood illnesses such as cystic fibrosis and type one diabetes are reaching adulthood in unprecedented numbers. That means they are also struggling with college, relationships, fertility and employment. Laurie Edwards, a health journExploring COVID-19 in Diabetes: A Look at Disease Management & Risk
https://reachmd.com/programs/diabetes-discourse/exploring-covid-19-in-diabetes-a-look-at-disease-management-risk/12585/Should patients with diabetes be concerned about getting the COVID-19 vaccine?Optimizing Anti-VEGF Selection in Diabetic Macular Edema
https://reachmd.com/programs/eye-on-ocular-health/optimizing-anti-vegf-selection-in-diabetic-macular-edema/60933/Choosing the right anti-VEGF therapy is an important part of optimizing long-term outcomes for patients with diabetic macular edema (DME). Discover how to select the right therapy, incorporate longer-acting agents into practice, and balance durability and long-term disease management with Dr. MichaeWhat’s Happening in Hypoglycemia?
https://reachmd.com/programs/diabetes-discourse/whats-happening-in-hypoglycemia/4692/The frequency of hypoglycemic events for both type 1 and type 2 diabetics increases due to tight blood glucose control and more intensive treatment schedules. The disease differs significantly between type 1 and type 2 in the body’s defense mechanism of decreasing insulin concentration. Join host DrNo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-emerging-ckd-therapies-in-t1d/36524/Gain insights in CKD screening practices, pathophysiology, and treatment from the results of the FINE-1 trial evaluating finerenone in patients with type 1 diabetes.